Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975455 · ClinicalTrials.gov registry record
Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer
A clinical trial of Microscopic or Gross Hematuria, sponsored by Predictive Biosciences.
- Completed
- Registry status
- 1,400
- Enrollment target
- 13
- Study locations
NCT00975455: Completed study of Microscopic or Gross Hematuria, sponsored by Predictive Biosciences.
NCT00975455 is a study of Microscopic or Gross Hematuria that has completed, run by Predictive Biosciences. The registered enrollment target is 1,400 participants. The trial reports 13 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00975455, a study of Microscopic or Gross Hematuria, has completed, sponsored by Predictive Biosciences.
- COMPLETED
- Registry status
- 1,400 participants
- Enrollment target
- 13
- Study locations
Study Summary
The purpose of the study is to evaluate subjects with gross or microscopic hematuria undergoing scheduled cystoscopy to determine the absence or presence of bladder cancer.
Conditions Studied
Study Locations (13)
Florida
- Atlantic Urological Associates - Daytona Beach
- Winter Park Urology - Orlando
New Jersey
- Coastal Urology Associates - Brick
- Associates in Urology - Orange
New York
- Community Care Physicians - Albany
- Hudson Valley Urology - Poughkeepsie
Texas
- Urology Clinics of North Texas - Dallas
- Urology San Antonio Research - San Antonio
Indiana
- Metropolitan Urology - Jeffersonville
Minnesota
- Mayo Validation Support Services - Rochester
North Carolina
- Eastern Urological Associates - Greenville
Ohio
- The Urology Group - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,400 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-01 |
What the finished NCT00975455 record still lists
NCT00975455 is an observational study that tracks outcomes without assigning an intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Microscopic or Gross Hematuria appearing as the primary indexed condition, and to 0 interventions.
NCT00975455 lists 13 locations in 9 states (Florida, New Jersey, New York).
Frequently Asked Questions
What is clinical trial NCT00975455 about?
NCT00975455 is a clinical study titled "Hematuria Evaluation Trial for Subjects With Microscopic or Gross Hematuria to Determine the Absence or Presence of Bladder Cancer". The purpose of the study is to evaluate subjects with gross or microscopic hematuria undergoing scheduled cystoscopy to determine the absence or presence of bladder cancer.
What is the current status of trial NCT00975455?
This trial is currently completed. The enrollment target is 1,400 participants. The study started on 2009-07. Estimated completion is 2011-01.
What conditions does trial NCT00975455 study?
This clinical trial studies the following conditions: Microscopic or Gross Hematuria.
Who is sponsoring clinical trial NCT00975455?
This trial is sponsored by Predictive Biosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00975455 being conducted?
This trial has 13 study locations across Florida, Indiana, Minnesota, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
- NCT04250857 · 1,400 participants
HeartStart FRx Defibrillator Event Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia